human primary Search Results


normal prostate epithelial cells prec  (ATCC)
96
ATCC normal prostate epithelial cells prec
Normal Prostate Epithelial Cells Prec, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/normal prostate epithelial cells prec/product/ATCC
Average 96 stars, based on 1 article reviews
normal prostate epithelial cells prec - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier
c 12720  (PromoCell)
96
PromoCell c 12720
C 12720, supplied by PromoCell, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/c 12720/product/PromoCell
Average 96 stars, based on 1 article reviews
c 12720 - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier
human umbilical vein endothelial cells huvecs  (ATCC)
99
ATCC human umbilical vein endothelial cells huvecs
Human Umbilical Vein Endothelial Cells Huvecs, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human umbilical vein endothelial cells huvecs/product/ATCC
Average 99 stars, based on 1 article reviews
human umbilical vein endothelial cells huvecs - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier
neonatal dermal fibroblasts  (ATCC)
98
ATCC neonatal dermal fibroblasts
Neonatal Dermal Fibroblasts, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/neonatal dermal fibroblasts/product/ATCC
Average 98 stars, based on 1 article reviews
neonatal dermal fibroblasts - by Bioz Stars, 2026-03
98/100 stars
  Buy from Supplier
parental hcc cells  (Celprogen Inc)
90
Celprogen Inc parental hcc cells
Fig. 1 Characterization of Cancer Stem Cells from human <t>HCC</t> tissues. (A) Real-time analysis of Oct 4, CD 133, Nestin, telom- erase, SSEA-4, AFP and CEA mRNA expres- sion in HCC stem cell under self-renewal con- dition (HSC-SR), under differentiation (HSC- DF) and HepG2 <t>HCC</t> <t>cells.</t> All the markers are significantly up-regulated in HCC cancer stem cells. *P 0.05 when compared with HepG2 group. (B) FACS analysis of HCC stem cells on day 1 before cell sorting. Results are given as the percentage of Oct-4 and CD133
Parental Hcc Cells, supplied by Celprogen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/parental hcc cells/product/Celprogen Inc
Average 90 stars, based on 1 article reviews
parental hcc cells - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
normal human dermal fibroblasts nhdf  (ATCC)
99
ATCC normal human dermal fibroblasts nhdf
Fig. 1 Characterization of Cancer Stem Cells from human <t>HCC</t> tissues. (A) Real-time analysis of Oct 4, CD 133, Nestin, telom- erase, SSEA-4, AFP and CEA mRNA expres- sion in HCC stem cell under self-renewal con- dition (HSC-SR), under differentiation (HSC- DF) and HepG2 <t>HCC</t> <t>cells.</t> All the markers are significantly up-regulated in HCC cancer stem cells. *P 0.05 when compared with HepG2 group. (B) FACS analysis of HCC stem cells on day 1 before cell sorting. Results are given as the percentage of Oct-4 and CD133
Normal Human Dermal Fibroblasts Nhdf, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/normal human dermal fibroblasts nhdf/product/ATCC
Average 99 stars, based on 1 article reviews
normal human dermal fibroblasts nhdf - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier
neonatal  (ATCC)
94
ATCC neonatal
Fig. 1 Characterization of Cancer Stem Cells from human <t>HCC</t> tissues. (A) Real-time analysis of Oct 4, CD 133, Nestin, telom- erase, SSEA-4, AFP and CEA mRNA expres- sion in HCC stem cell under self-renewal con- dition (HSC-SR), under differentiation (HSC- DF) and HepG2 <t>HCC</t> <t>cells.</t> All the markers are significantly up-regulated in HCC cancer stem cells. *P 0.05 when compared with HepG2 group. (B) FACS analysis of HCC stem cells on day 1 before cell sorting. Results are given as the percentage of Oct-4 and CD133
Neonatal, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/neonatal/product/ATCC
Average 94 stars, based on 1 article reviews
neonatal - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier
human aortic endothelial cells  (PromoCell)
96
PromoCell human aortic endothelial cells
Fig. 1 Characterization of Cancer Stem Cells from human <t>HCC</t> tissues. (A) Real-time analysis of Oct 4, CD 133, Nestin, telom- erase, SSEA-4, AFP and CEA mRNA expres- sion in HCC stem cell under self-renewal con- dition (HSC-SR), under differentiation (HSC- DF) and HepG2 <t>HCC</t> <t>cells.</t> All the markers are significantly up-regulated in HCC cancer stem cells. *P 0.05 when compared with HepG2 group. (B) FACS analysis of HCC stem cells on day 1 before cell sorting. Results are given as the percentage of Oct-4 and CD133
Human Aortic Endothelial Cells, supplied by PromoCell, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human aortic endothelial cells/product/PromoCell
Average 96 stars, based on 1 article reviews
human aortic endothelial cells - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier
human coronary artery endothelial cells  (ATCC)
95
ATCC human coronary artery endothelial cells
Fig. 1 Characterization of Cancer Stem Cells from human <t>HCC</t> tissues. (A) Real-time analysis of Oct 4, CD 133, Nestin, telom- erase, SSEA-4, AFP and CEA mRNA expres- sion in HCC stem cell under self-renewal con- dition (HSC-SR), under differentiation (HSC- DF) and HepG2 <t>HCC</t> <t>cells.</t> All the markers are significantly up-regulated in HCC cancer stem cells. *P 0.05 when compared with HepG2 group. (B) FACS analysis of HCC stem cells on day 1 before cell sorting. Results are given as the percentage of Oct-4 and CD133
Human Coronary Artery Endothelial Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human coronary artery endothelial cells/product/ATCC
Average 95 stars, based on 1 article reviews
human coronary artery endothelial cells - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier
adult human skeletal muscle derived cells hskmdcs  (Cook MyoSite Inc)
94
Cook MyoSite Inc adult human skeletal muscle derived cells hskmdcs
Fig. 1 Characterization of Cancer Stem Cells from human <t>HCC</t> tissues. (A) Real-time analysis of Oct 4, CD 133, Nestin, telom- erase, SSEA-4, AFP and CEA mRNA expres- sion in HCC stem cell under self-renewal con- dition (HSC-SR), under differentiation (HSC- DF) and HepG2 <t>HCC</t> <t>cells.</t> All the markers are significantly up-regulated in HCC cancer stem cells. *P 0.05 when compared with HepG2 group. (B) FACS analysis of HCC stem cells on day 1 before cell sorting. Results are given as the percentage of Oct-4 and CD133
Adult Human Skeletal Muscle Derived Cells Hskmdcs, supplied by Cook MyoSite Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/adult human skeletal muscle derived cells hskmdcs/product/Cook MyoSite Inc
Average 94 stars, based on 1 article reviews
adult human skeletal muscle derived cells hskmdcs - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier
mammary epithelial cells hmec  (ATCC)
99
ATCC mammary epithelial cells hmec
Fig. 1 Characterization of Cancer Stem Cells from human <t>HCC</t> tissues. (A) Real-time analysis of Oct 4, CD 133, Nestin, telom- erase, SSEA-4, AFP and CEA mRNA expres- sion in HCC stem cell under self-renewal con- dition (HSC-SR), under differentiation (HSC- DF) and HepG2 <t>HCC</t> <t>cells.</t> All the markers are significantly up-regulated in HCC cancer stem cells. *P 0.05 when compared with HepG2 group. (B) FACS analysis of HCC stem cells on day 1 before cell sorting. Results are given as the percentage of Oct-4 and CD133
Mammary Epithelial Cells Hmec, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mammary epithelial cells hmec/product/ATCC
Average 99 stars, based on 1 article reviews
mammary epithelial cells hmec - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier
normal human airway epithelial cells  (ATCC)
98
ATCC normal human airway epithelial cells
Fig. 1 Characterization of Cancer Stem Cells from human <t>HCC</t> tissues. (A) Real-time analysis of Oct 4, CD 133, Nestin, telom- erase, SSEA-4, AFP and CEA mRNA expres- sion in HCC stem cell under self-renewal con- dition (HSC-SR), under differentiation (HSC- DF) and HepG2 <t>HCC</t> <t>cells.</t> All the markers are significantly up-regulated in HCC cancer stem cells. *P 0.05 when compared with HepG2 group. (B) FACS analysis of HCC stem cells on day 1 before cell sorting. Results are given as the percentage of Oct-4 and CD133
Normal Human Airway Epithelial Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/normal human airway epithelial cells/product/ATCC
Average 98 stars, based on 1 article reviews
normal human airway epithelial cells - by Bioz Stars, 2026-03
98/100 stars
  Buy from Supplier

Image Search Results


Fig. 1 Characterization of Cancer Stem Cells from human HCC tissues. (A) Real-time analysis of Oct 4, CD 133, Nestin, telom- erase, SSEA-4, AFP and CEA mRNA expres- sion in HCC stem cell under self-renewal con- dition (HSC-SR), under differentiation (HSC- DF) and HepG2 HCC cells. All the markers are significantly up-regulated in HCC cancer stem cells. *P 0.05 when compared with HepG2 group. (B) FACS analysis of HCC stem cells on day 1 before cell sorting. Results are given as the percentage of Oct-4 and CD133

Journal: Journal of cellular and molecular medicine

Article Title: Functional analysis of microRNAs in human hepatocellular cancer stem cells.

doi: 10.1111/j.1582-4934.2011.01282.x

Figure Lengend Snippet: Fig. 1 Characterization of Cancer Stem Cells from human HCC tissues. (A) Real-time analysis of Oct 4, CD 133, Nestin, telom- erase, SSEA-4, AFP and CEA mRNA expres- sion in HCC stem cell under self-renewal con- dition (HSC-SR), under differentiation (HSC- DF) and HepG2 HCC cells. All the markers are significantly up-regulated in HCC cancer stem cells. *P 0.05 when compared with HepG2 group. (B) FACS analysis of HCC stem cells on day 1 before cell sorting. Results are given as the percentage of Oct-4 and CD133

Article Snippet: Human hepatocellular CSCs and parental HCC cells were provided by Celprogen Inc. (San Pedro, CA, USA).

Techniques: FACS

Fig. 4 HCC stem cells are resistant to con- ventional chemotherapy. (A, C) After serum starvation of cultured cells overnight, sorafenib and doxorubicin were added at various concentrations (10 3–10 10 M) and cell viability was assessed after 72 hrs. IC50 graph of high-content image analysis of human hepatocytes and HCC stem cells treated by sorafenib and doxorubicin was illustrated. Quantitative data of MTS assay in the sorafenib treated cells were calcu- lated for IC50 with XLfit software, which is marked in the middle of the box. (B, D) IC50 of sorafenib and doxorubicin in hepato- cytes and HCC stem cells is illustrated in bar graph. HCC stem cells under either self- renewal (HSC-SR) or differentiation (HSC- DF) are more resistance to sorafenib and doxorubicin than HepG2 cells and normal liver stem cells. IC50 results are expressed as the mean S.E. of eight different exper- iments. (E) Groups of five SCID Berge mice were selected 8–10 weeks old per treat- ment group. The human HSC-SRs (1000) as well as parental HCC cells (5 106) were injected subcutaneously and allowed to engraft for 10 days. At day 10 the tumour was visible, and then the doxorubicin treat- ment was started and the mice received the desired concentration of the drug intraper- oteneal three times per week for 14 days. At the end of the 14 days the tumour was dis- sociated into single cell suspension and assayed with Almar Blue to determine per- cent inhibition of the drug. (F, G) Differential expression of CD133 and let-7a in vivo following treatment with doxorubicin by real-time PCR is shown. Data represent percentage change in expression in doxo- cibicin-treated tumours compared with controls. *P 0.05 relative to controls.

Journal: Journal of cellular and molecular medicine

Article Title: Functional analysis of microRNAs in human hepatocellular cancer stem cells.

doi: 10.1111/j.1582-4934.2011.01282.x

Figure Lengend Snippet: Fig. 4 HCC stem cells are resistant to con- ventional chemotherapy. (A, C) After serum starvation of cultured cells overnight, sorafenib and doxorubicin were added at various concentrations (10 3–10 10 M) and cell viability was assessed after 72 hrs. IC50 graph of high-content image analysis of human hepatocytes and HCC stem cells treated by sorafenib and doxorubicin was illustrated. Quantitative data of MTS assay in the sorafenib treated cells were calcu- lated for IC50 with XLfit software, which is marked in the middle of the box. (B, D) IC50 of sorafenib and doxorubicin in hepato- cytes and HCC stem cells is illustrated in bar graph. HCC stem cells under either self- renewal (HSC-SR) or differentiation (HSC- DF) are more resistance to sorafenib and doxorubicin than HepG2 cells and normal liver stem cells. IC50 results are expressed as the mean S.E. of eight different exper- iments. (E) Groups of five SCID Berge mice were selected 8–10 weeks old per treat- ment group. The human HSC-SRs (1000) as well as parental HCC cells (5 106) were injected subcutaneously and allowed to engraft for 10 days. At day 10 the tumour was visible, and then the doxorubicin treat- ment was started and the mice received the desired concentration of the drug intraper- oteneal three times per week for 14 days. At the end of the 14 days the tumour was dis- sociated into single cell suspension and assayed with Almar Blue to determine per- cent inhibition of the drug. (F, G) Differential expression of CD133 and let-7a in vivo following treatment with doxorubicin by real-time PCR is shown. Data represent percentage change in expression in doxo- cibicin-treated tumours compared with controls. *P 0.05 relative to controls.

Article Snippet: Human hepatocellular CSCs and parental HCC cells were provided by Celprogen Inc. (San Pedro, CA, USA).

Techniques: Cell Culture, MTS Assay, Software, Injection, Concentration Assay, Suspension, Inhibition, Quantitative Proteomics, In Vivo, Real-time Polymerase Chain Reaction, Expressing